Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2010
04/15/2010US20100093761 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
04/15/2010US20100093760 Methods for identifying compounds that modulate cell signaling and methods employing such compounds
04/15/2010US20100093759 Bicyclic anilide heterocyclic cgrp receptor antagonists
04/15/2010US20100093758 Pyridine sulfonamide modulators of endothelin-a receptor
04/15/2010US20100093757 Therapeutic agents 414
04/15/2010US20100093756 HETEROARYL SUBSTITUTED THIENO[2,3-d]PYRIMIDINE AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS
04/15/2010US20100093755 Ketoconazole Enantiomer in Humans
04/15/2010US20100093754 Pharmaceutical Compositions Comprising Flibanserin and a Further Agent in the Treatment of Sexual Disorders
04/15/2010US20100093753 Biphenyl compounds useful as muscarinic receptor antagonists
04/15/2010US20100093752 Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives with protease inhibitors
04/15/2010US20100093751 Indolizineacetic Acids and Their Therapeutic Use as Ligands of the CRTH2 Receptor
04/15/2010US20100093750 Combination treatment of solid cancers with antimetabolites and tyrosine kinase inhibitors
04/15/2010US20100093749 Compounds
04/15/2010US20100093748 Substituted piperidines having protein kinase inhibiting activity
04/15/2010US20100093747 Method of inducing negative chemotaxis
04/15/2010US20100093746 3-(heteroaryl-oxy)-2-alkyl-1-aza-bicycloalkyl derivatives as alpha. 7-nachr ligands for the treatment of cns diseases
04/15/2010US20100093745 Therapeutic agent or prophylactic agent for demyelinating disease comprising amino alcohol derivative as active ingredient
04/15/2010US20100093744 Thioglucose spiroketal derivative and use thereof as therapeutic agent for diabetes
04/15/2010US20100093743 Carbamic acid compounds comprising a bicyclic heteroaryl group as hdac inhibitors
04/15/2010US20100093742 Pterin analogs
04/15/2010US20100093741 Certain chemical entities, compositions and methods
04/15/2010US20100093740 5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine derivatives
04/15/2010US20100093739 Method for decreasing capillary permeability in the retina
04/15/2010US20100093738 Fungicidal Compounds and Fungicidal Compositions
04/15/2010US20100093737 Nucleoside and Nucleotide Analogues with Quaternary Carbon Centers and Methods of Use
04/15/2010US20100093736 Aminoalcohol and biocide compositions for aqueous based systems
04/15/2010US20100093735 Cytokine inhibitors
04/15/2010US20100093734 Cytokine inhibitors
04/15/2010US20100093733 Amide and urea derivatives for the treatment of metabolic diseases
04/15/2010US20100093732 Acid Addition Salts, Hydrates and Polymorphs of 5-(2,4-Dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic Acid Ethylamide and Formulations Comprising These Forms
04/15/2010US20100093731 Modulators for amyloid beta
04/15/2010US20100093730 Novel compounds as calcium channel blockers
04/15/2010US20100093729 Substituted gamma lactams as therapeutic agents
04/15/2010US20100093728 Novel substituted bipyridine derivatives and their use as adenosine receptor ligands
04/15/2010US20100093727 Compounds and methods of use
04/15/2010US20100093726 Novel 4-amino-quinoline derivatives useful as anti-malaria drugs
04/15/2010US20100093725 Semi-solid formulations of phospholipase enzyme inhibitors
04/15/2010US20100093724 Azaindazole Compounds As CCR1 Receptor Antagonists
04/15/2010US20100093723 HETEROCYCLYL AND CYCLOALKYL SUBSTITUTED THIENO[2,3 d]PYRIMIDINE AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS
04/15/2010US20100093722 HETEROARYL AND PHENYL SUBSTITUTED THIENO[2,3-d]PYRIMIDINES AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS
04/15/2010US20100093721 PHENYL AND HETEROARYL SUBSTITUTED THIENO[2,3-d]PYRIMIDINES AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS
04/15/2010US20100093720 Macrocyclic antagonists of the motilin receptor for treatment of gastrointestinal dysmotility disorders
04/15/2010US20100093719 Pharmacokinetically improved compounds
04/15/2010US20100093718 Compounds
04/15/2010US20100093717 Triazole compounds that modulate hsp90 activity
04/15/2010US20100093716 Therapeutic methods using wrn binding molecules
04/15/2010US20100093714 AMIDES OF THIENO[2,3-d]PYRIMIDINE AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS
04/15/2010US20100093713 Beta-carbolines useful for treating inflammatory disease
04/15/2010US20100093712 Two-component pharmaceutical composition for the treatment of pain
04/15/2010US20100093711 Organic compounds
04/15/2010US20100093710 Galenical form for the administration of paracetamol by transmucous means
04/15/2010US20100093709 Tricyclic delta opioid modulators
04/15/2010US20100093708 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
04/15/2010US20100093706 Multimediator transporter inhibitors for use in treatment of central nervous system disorders
04/15/2010US20100093705 Therapeutic agents, and methods of making and using the same
04/15/2010US20100093704 Novel psychotropic agents having glutamate nmda activity
04/15/2010US20100093703 Substituted arylsulphonylglycines, the preparation thereof and the use thereof as pharmaceutical compositions
04/15/2010US20100093702 METHYLENE AMINES OF THIENO[2,3-d]PYRIMIDINE AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS
04/15/2010US20100093701 Combination therapy comprising angiotensin receptor blockers and vasopressin receptor antagonists
04/15/2010US20100093700 Methods of Treating Mood Disorders
04/15/2010US20100093699 Compounds and uses thereof - 177
04/15/2010US20100093698 Aminotriazolopyridines, compositions thereof, and methods of treatment therewith
04/15/2010US20100093697 Substituted Imidazopyridine Derivatives As Melanocortin-4 Receptor Antagonists
04/15/2010US20100093696 2-amino pyrimidine compounds
04/15/2010US20100093695 Substituted N-Arylsulfonylheterocyclic Amines As Gamma-Secretase Inhibitors
04/15/2010US20100093694 Compounds for the Treatment of Hepatitis C
04/15/2010US20100093693 Modulators of cellular adhesion
04/15/2010US20100093692 Piperidinyl-piperidine and piperazinyl-piperidine for use in the treatment of diabetes or pain
04/15/2010US20100093691 Topical formulations
04/15/2010US20100093690 5-phenylthiazole derivatives and use as pi3 kinase inhibitors
04/15/2010US20100093689 Heteroaryl compounds as p2y1 receptor inhibitors
04/15/2010US20100093688 Porphyrin catalysts and methods of use thereof
04/15/2010US20100093687 Method Of Treating Disorder Related To High Cholesterol Concentration
04/15/2010US20100093686 Coatings with crystallized active agent(s) and methods
04/15/2010US20100093685 Nitric oxide releasing steroids
04/15/2010US20100093684 Synergistic interaction of notch-1 inhibitors with glucocorticoids
04/15/2010US20100093683 Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with a proteasome inhibitor
04/15/2010US20100093682 Lipid composition having excellent shape retention property and product
04/15/2010US20100093681 Napadisylate salt of 5-(2--1-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one as agonist of the beta 2 adrenergic receptor
04/15/2010US20100093680 Use of 3-alpha-androstanediol, optionally in combination with a 5-ht1a agonist, in the treatment of sexual dysfunction
04/15/2010US20100093679 Drospirenone for hormone replacement therapy
04/15/2010US20100093678 Compositions and methods of the treatment of obesity and osteoporosis
04/15/2010US20100093677 Method of inducing negative chemotaxis
04/15/2010US20100093676 Polyaphron topical composition with vitamin d
04/15/2010US20100093675 Novel method
04/15/2010US20100093674 Skin cancer prevention method and product
04/15/2010US20100093673 Pain relieving patch
04/15/2010US20100093672 Use of s1p receptor modulator
04/15/2010US20100093671 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
04/15/2010US20100093670 Compounds for the treatment of angiogenesis
04/15/2010US20100093669 Methods for preparing oxazolidinones and compositions containing them
04/15/2010US20100093668 N,n'-2,4-dianilinopyrimidine derivatives, preparation thereof as drugs, pharmaceutical compositions essentially as ikk inhibitors
04/15/2010US20100093667 Salts of hiv inhibitor compounds
04/15/2010US20100093665 Silylated piperidine derivatives
04/15/2010US20100093664 Compositions useful for reducing nephrotoxicity and methods of use thereof
04/15/2010US20100093663 Sulfoalkyl Ether Cyclodextrin Compositions
04/15/2010US20100093662 Novel amphiphilic cyclodextrin derivatives
04/15/2010US20100093661 Composition comprising chitosan and an acidic drug for oral controlled release
04/15/2010US20100093660 Anti-tumor composition comprising tissue-accumulating chitosan gel
04/15/2010US20100093659 Polyvalent bioconjugates
1 ... 2307 2308 2309 2310 2311 2312 2313 2314 2315 2316 2317 2318 2319 2320 2321 2322 2323 2324 2325 2326 2327 ... 7860